{
    "2019-06-25": [
        [
            {
                "time": "2019-06-26",
                "original_text": "复星医药选举任倩为公司监事会主席",
                "features": {
                    "keywords": [
                        "复星医药",
                        "监事会主席",
                        "任倩"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "复星医药控股子公司拟不超过7.47亿元揽力思特制药97.8251%股权",
                "features": {
                    "keywords": [
                        "复星医药",
                        "力思特制药",
                        "收购",
                        "股权"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "公告精选：普洛药业等业绩预增；科融环境拟将注册地搬迁至雄安新区",
                "features": {
                    "keywords": [
                        "普洛药业",
                        "业绩预增",
                        "科融环境",
                        "雄安新区"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "环保"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "复星医药收购力思特制药 推进外延式扩张战略",
                "features": {
                    "keywords": [
                        "复星医药",
                        "力思特制药",
                        "外延式扩张"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-25",
                "original_text": "海外医药新闻发布 【西南医药朱国广陈铁林团队】",
                "features": {
                    "keywords": [
                        "海外医药",
                        "西南医药",
                        "朱国广",
                        "陈铁林"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "复星医药子公司拟收购力思特制药97.83%股份",
                "features": {
                    "keywords": [
                        "复星医药",
                        "力思特制药",
                        "子公司",
                        "收购"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2019-06-26",
                "original_text": "生物医药行业周报:政策密集推出,短期建议抓紧政策免疫细分领域",
                "features": {
                    "keywords": [
                        "生物医药",
                        "政策",
                        "免疫",
                        "细分领域"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}